Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
Date:2/4/2009

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the company's corporate overview on Tuesday, February 10, 2009 at 9:00am Eastern Time (6:00am Pacific Time) during the BIO CEO and Investor Conference at the Waldorf Astoria Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contacts:   Anna Gralinska
                Director, Investor Relations
                Cadence Pharmaceuticals, Inc.
                858-436-1452


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
4. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
5. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
6. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
7. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
9. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
10. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
11. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Campbell Agency has once again teamed up with Stillwaters Cancer Support Services and ... their families. Stillwaters provides individual and family counseling, support groups, workshops and educational ...
(Date:7/29/2015)... ... July 29, 2015 , ... Wedding season is in full swing, which means bridal beauty ... of looking good on the big day. Every bride wants to look and feel beautiful, ... , According to a recent study by the American Academy of ...
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... ... Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a ... bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We are ...
(Date:7/29/2015)... Palatine, IL (PRWEB) , ... July 29, 2015 , ... ... the ever-expanding population of children with autism, Little City took a proactive stance and ... and occupied. The Coleman Foundation grant provides valuable support to building the third home. ...
(Date:7/29/2015)... ... July 29, 2015 , ... The New Foundation ... which will by the end will cost the 501(c) organization nearly $1 million, will ... anti-ligature requirements. , “We took it down to the studs,” said Geraldine Leary, ...
Breaking Medicine News(10 mins):Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3
... WAYNE, N.J., July 9 Today, Bayer HealthCare Pharmaceuticals ... designed to make infusion of recombinant factor VIII easier ... caregivers. The centerpiece of the program is an ... allows patients to practice the technique of self-injection without ...
... U.S. taking steps to handle virus, anticipated return in ... -- The initial scare posed by the sudden emergence ... federal officials are warning against complacency and taking no ... in the fall. , On Thursday, Health and Human ...
... , ... in Philadelphia, PA , ... Horsham, PA (Vocus) -- The Drug Information Association (DIA), in collaboration ... will host eDrug Listing and Establishment Registration--FDA and Industry: Overview and Lessons Learned ...
... Technologies, Inc., a leading provider of software and services for health ... the Healthcare Informatics Top 100 listing of ... HCI 100 listing was published in the June 2009 ... online at the magazine,s Web site. Netsmart,s ranking ...
... more attention nationwide as a successful strategy to improve the ... the Center for Disease Control and Prevention, care for chronic ... 75 percent of medical care costs in the United States. ... to help members avoid, or better manage, two serious chronic ...
... EDEN PRAIRIE, Minn., July 9 TCS Healthcare Technologies (TCS), ... applications, announced today that TCS is expanding its software hosting ... a Service (SaaS) provider. , , Rob Pock, TCS ... been hosting Acuity AnyWare, a care management software application developed ...
Cached Medicine News:Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 2Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 3Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 4Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 5Health News:Swine Flu Summit Focuses on Preparedness 2Health News:Swine Flu Summit Focuses on Preparedness 3Health News:Swine Flu Summit Focuses on Preparedness 4Health News:Swine Flu Summit Focuses on Preparedness 5Health News:Swine Flu Summit Focuses on Preparedness 6Health News:Swine Flu Summit Focuses on Preparedness 7Health News:Swine Flu Summit Focuses on Preparedness 8Health News:Swine Flu Summit Focuses on Preparedness 9Health News:Swine Flu Summit Focuses on Preparedness 10Health News:Swine Flu Summit Focuses on Preparedness 11Health News:DIA Workshop Features Industry and FDA for Discussion of Best Practices for Electronic Establishment Registration and Product Listing 2Health News:Netsmart Technologies Ranked in Healthcare Informatics Top 100 2Health News:Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes 2Health News:Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes 3Health News:TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM) 2Health News:TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM) 3
(Date:7/29/2015)... BURLINGTON, Mass. , July 29, 2015   ... device market in Europe will ... unfavorable economic conditions across the Eurozone. On a longer ... the elderly, obese, and physically active will increase the ... treatment via arthroscopy devices and orthopedic soft tissue solutions. ...
(Date:7/29/2015)... , July 29, 2015  PDL BioPharma, Inc. ... entered into a revenue interest assignment agreement (the "Agreement") ... Inc. (NASDAQ: ARIA ) with up to $200 ... on the net revenues of Iclusig ® (ponatinib).  ... in two tranches of $50 million each, with the ...
(Date:7/29/2015)... 29, 2015  Henry Schein, Inc. (NASDAQ: ... care products and services to office-based dental, animal ... quarter financial results. Net sales for ... billion, an increase of 0.5% compared with the ... growth in local currencies and a 7.0% decline ...
Breaking Medicine Technology:The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25
... HONG KONG, March 11, 2012 /PRNewswire-Asia/ -- Sihuan ... Pharmaceutical" or the "Company"), a leading pharmaceutical company ... China by market share, announced today that its ... international and innovative anti-hypertensive drug developed by its ...
... tissue imaging with 3D ultrasound both at therapy ... radiotherapy at University Hospital Galway (UHG). The majority ... the clinic will benefit from a new technology ... each treatment. The Elekta Clarity® 3D system provides ...
Cached Medicine Technology:Sihuan Pharmaceutical Achieves Important R&D Breakthrough 2Sihuan Pharmaceutical Achieves Important R&D Breakthrough 3Irish Hospital Uses Elekta's Clarity 3D Ultrasound to Guide Prostate Cancer Radiotherapy 2Irish Hospital Uses Elekta's Clarity 3D Ultrasound to Guide Prostate Cancer Radiotherapy 3
Flattened paddle tip with generous surface area is ideal for manipulating tissue, rotating and cracking the nucleus. Round knurled handle....
Smaller than the kuglen hook, this manipulator offers excellent grasping or lifting of the nucleus. Blunt finger-like 0.5 mm two-prong tip. Round knurled handle with dull finish. Straight....
Squeeze handle nucleus cracker....
Used when dislocating the lens. Great for chopping during phacoemulsification. Helpful in ushering the IOL out of eye. Useful to reduce possibility of iris tuck with anterior chamber IOL placement....
Medicine Products: